TABLE 1.
Association between lncRNA HNRNPU-AS1 expression and clinicopathological features in cervical cancera
| Clinical feature | No. in miR-205-5p expression group |
Chi square | P value | |
|---|---|---|---|---|
| Low | High | |||
| All cases (no.) | 20 | 21 | ||
| Age (yr) | 0.223 | 0.636 | ||
| ≥50 | 9 | 11 | ||
| <50 | 11 | 10 | ||
| Tumor size (cm) | 11.607 | 0.001 | ||
| ≥4 | 12 | 2 | ||
| <4 | 8 | 19 | ||
| FIGO stage | 0.034 | 0.853 | ||
| I | 12 | 12 | ||
| II | 8 | 9 | ||
| Lymph node metastasis | 1.953 | 0.162 | ||
| Positive | 11 | 7 | ||
| Negative | 9 | 14 | ||
| Histology | 0.034 | 0.853 | ||
| Squamous | 8 | 9 | ||
| Adenocarcinoma | 12 | 12 | ||
a
The median expression level of lncRNA HNRNPU-AS1 was used as the cutoff. Pearson chi-square tests were used to analyze the association between lncRNA HNRNPU-AS1 expression and clinical features. FIGO, International Federation of Gynecology and Obstetrics.